Vivos Therapeutics Files Q1 2025 10-Q
Ticker: VVOS · Form: 10-Q · Filed: May 15, 2025 · CIK: 1716166
| Field | Detail |
|---|---|
| Company | Vivos Therapeutics, Inc. (VVOS) |
| Form Type | 10-Q |
| Filed Date | May 15, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, medical-devices
TL;DR
Vivos Therapeutics filed its Q1 2025 10-Q, showing updated financials for product and service segments.
AI Summary
Vivos Therapeutics, Inc. filed its 10-Q for the period ending March 31, 2025. The company, formerly Vivos BioTechnologies, Inc., is based in Littleton, CO, and operates in the Surgical & Medical Instruments & Apparatus sector. The filing covers the first quarter of 2025, with financial data for both product and service segments being reported.
Why It Matters
This filing provides investors with the latest financial performance and operational updates for Vivos Therapeutics, Inc. during the first quarter of 2025.
Risk Assessment
Risk Level: medium — As a 10-Q filing, it contains detailed financial information and operational updates which can significantly impact investor decisions, but it does not represent a major event like an acquisition or bankruptcy.
Key Numbers
- 20250331 — Reporting Period End Date (The 10-Q covers financial performance up to this date.)
- 20250515 — Filing Date (The date the report was officially submitted to the SEC.)
Key Players & Entities
- Vivos Therapeutics, Inc. (company) — Filer
- Vivos BioTechnologies, Inc. (company) — Former company name
- Littleton, CO (location) — Business address
- 3841 (industry_code) — Standard Industrial Classification
FAQ
What is the primary business of Vivos Therapeutics, Inc. according to the SIC code?
Vivos Therapeutics, Inc. is classified under SIC code 3841, which corresponds to Surgical & Medical Instruments & Apparatus.
What was the former name of Vivos Therapeutics, Inc.?
The former name of Vivos Therapeutics, Inc. was Vivos BioTechnologies, Inc., with a name change occurring on September 1, 2017.
What is the fiscal year end for Vivos Therapeutics, Inc.?
The fiscal year end for Vivos Therapeutics, Inc. is December 31.
What period does this 10-Q filing cover?
This 10-Q filing covers the period ending March 31, 2025.
Where is Vivos Therapeutics, Inc. headquartered?
Vivos Therapeutics, Inc. is headquartered at 7921 Southpark Plaza, Suite 210, Littleton, CO 80120.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 15, 2025 regarding Vivos Therapeutics, Inc. (VVOS).